Jonathan Levin to Anti-Retroviral Agents
This is a "connection" page, showing publications Jonathan Levin has written about Anti-Retroviral Agents.
Connection Strength
0,654
-
The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study. BMC Palliat Care. 2017 Jul 13; 17(1):8.
Score: 0,104
-
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort. AIDS Res Ther. 2017; 14:26.
Score: 0,102
-
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults. AIDS. 2017 02 20; 31(4):577-582.
Score: 0,101
-
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study. AIDS. 2016 Feb 20; 30(4):635-44.
Score: 0,094
-
Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design. Contemp Clin Trials. 2015 Jul; 43:100-4.
Score: 0,089
-
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4? cell counts: findings from a cluster-randomized trial. AIDS. 2014 Feb 20; 28(4):569-76.
Score: 0,082
-
Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experience. S Afr Med J. 2008 Oct; 98(10):795-800.
Score: 0,056
-
Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study. Malar J. 2016 07 15; 15:361.
Score: 0,024